Literature DB >> 16781227

Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention.

Peter Elsman1, Arnoud W J van 't Hof, Menko-Jan de Boer, Harry Suryapranata, George F Borm, Jan C A Hoorntje, Jan Paul Ottervanger, A T Marcel Gosselink, Jan-Henk E Dambrink, Felix Zijlstra.   

Abstract

BACKGROUND: Left ventricular function and infarct size are strong predictors for prognosis after acute myocardial infarction (MI). Anterior MI is associated with greater reduction of left ventricular ejection fraction (LVEF) and worse prognosis. Our objective was to study whether the impact of infarct size on global LVEF is dependent of infarct location.
METHODS: We analyzed 888 patients treated with primary percutaneous coronary intervention for acute MI. Enzymatic infarct size and LVEF within 1 week were measured. In 490 patients (55%), LVEF was measured a second time at 6 months.
RESULTS: Every 1000 U/L of cumulative lactate dehydrogense release corresponded to a decrease of 4.7% (95% CI 4.1-5.3) in LVEF measured within 1 week post MI for left anterior descending coronary artery (LAD)-related infarcts and to a decrease of 2.4% (95% CI 1.7-3.1) in LVEF measured within 1 week post MI for non-LAD-related infarcts (P < .0001). Left ventricular ejection fraction measured 6 months post MI showed a decrease for every 1000 U/L cumulative lactate dehydrogense release of 4.8% (95% CI 4.2-5.3) for LAD and 2.4% (95% CI 1.7-3.1) for non-LAD-related infarcts (P < .0001). Multivariate correction for relevant clinical and angiographic data did not change these results.
CONCLUSION: In patients with a first acute MI treated with primary percutaneous coronary intervention, LAD-related infarcts show for a similar amount of myocardial necrosis as determined by enzymatic infarct size, a lower residual LVEF when compared with non-LAD-related infarcts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781227     DOI: 10.1016/j.ahj.2005.12.006

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Does the location of perfusion defects matter? An old question with a new answer.

Authors:  Mouaz H Al-Mallah; Waqas Qureshi
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

2.  B-type natriuretic peptide as a predictor of anterior wall location in patients with non-ST-elevation myocardial infarction.

Authors:  Rogério Bicudo Ramos; Célia M Strunz; Solange Desirée Avakian; José Antonio Ramires; Antonio de Padua Mansur
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

3.  Coronary collateral circulation: Effects on outcomes of acute anterior myocardial infarction after primary percutaneous coronary intervention.

Authors:  Bin Wang; Ya-Ling Han; Yi Li; Quan-Min Jing; Shou-Li Wang; Ying-Yan Ma; Geng Wang; Bo Luan; Xiao-Zeng Wang
Journal:  J Geriatr Cardiol       Date:  2011-06       Impact factor: 3.327

4.  Effect of multiple clinical factors on recurrent angina after percutaneous coronary intervention: A retrospective study from 398 ST-segment elevation myocardial infarction patients.

Authors:  Jing Zhang; Chengyu Liu; Chenliang Pan; Ming Bai; Jin Zhang; Yu Peng; Dingchang Zheng; Zheng Zhang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

Review 5.  Role of Cardiac Magnetic Resonance to Improve Risk Prediction Following Acute ST-Elevation Myocardial Infarction.

Authors:  Martin Reindl; Ingo Eitel; Sebastian Johannes Reinstadler
Journal:  J Clin Med       Date:  2020-04-07       Impact factor: 4.241

6.  Association of left anterior descending artery involvement on clinical outcomes among patients with STEMI presenting with and without out-of-hospital cardiac arrest.

Authors:  Mia Bertic; Christopher B Fordyce; Nima Moghaddam; John Cairns; Martha Mackay; Joel Singer; Terry Lee; Michele Perry-Arnesen; Wendy Tocher; Graham Wong
Journal:  Open Heart       Date:  2020-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.